David S. Wells

640 total citations
18 papers, 488 citations indexed

About

David S. Wells is a scholar working on Molecular Biology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, David S. Wells has authored 18 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cognitive Neuroscience and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in David S. Wells's work include Face Recognition and Perception (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Insect and Pesticide Research (2 papers). David S. Wells is often cited by papers focused on Face Recognition and Perception (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Insect and Pesticide Research (2 papers). David S. Wells collaborates with scholars based in United States and Canada. David S. Wells's co-authors include Frank W. Janssen, Hans W. Ruelius, John Fox, Thomas B. Marriott, Thomas A. Grover, Nancy Doyle, Jerry F. Hardisty, Susan Y. Smith, Jacquelin Jolette and W.C. Dauterman and has published in prestigious journals such as Analytical Chemistry, Journal of Agricultural and Food Chemistry and Annals of the New York Academy of Sciences.

In The Last Decade

David S. Wells

18 papers receiving 456 citations

Peers

Countries citing papers authored by David S. Wells

Since Specialization

Citations

This map shows the geographic impact of David S. Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Wells more than expected).

Fields of papers citing papers by David S. Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Wells. The network helps show where David S. Wells may publish in the future.

Co-authorship network of co-authors of David S. Wells

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Wells. A scholar is included among the top collaborators of David S. Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Wells. David S. Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Altering Metabolic Profiles of Drugs by Precision Deuteration: Reducing Mechanism-Based Inhibition of CYP2D6 by Paroxetine 2015 ·Journal of Pharmacology and Experimental Therapeutics ·Vinita Uttamsingh, Richard Gallegos, (unknown), Scott L. Harbeson, (unknown), Changfu Cheng, David S. Wells, Philip B. Graham, Robert E. Zelle, Roger D. Tung	35
2	Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects 2008 ·The Journal of Clinical Pharmacology ·Jean‐Francois Marier, Martin Béliveau, Samer Mouksassi, (unknown), (unknown), (unknown), (unknown), Hamim Zahir, David S. Wells, John Caminis	65
3	Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: Commercial kit evaluation and validation to support pharmacokinetic studies 2006 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Jean W. Lee, John Fox, (unknown), Damon I. Papac, Thomas A. Grover, David S. Wells	10
4	Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats 2006 ·Toxicologic Pathology ·Jacquelin Jolette, (unknown), Susan Y. Smith, Nancy Doyle, Jerry F. Hardisty, (unknown), Thomas B. Marriott, John Fox, David S. Wells	91
5	Identification of Carboxyl-Terminal Peptide Fragments of Parathyroid Hormone in Human Plasma at Low-Picomolar Levels by Mass Spectrometry 2005 ·Analytical Chemistry ·(unknown), (unknown), (unknown), Thomas A. Grover, David S. Wells	43
6	NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience 2000 ·Amino Acids ·Alan L. Mueller, Linda D. Artman, Manuel F. Balandrin, E.J. Brady, (unknown), Eric G. DelMar, (unknown), Thomas B. Marriott, Scott T. Moe, J L Raszkiewicz, (unknown), David S. Wells	3
7	NPS 1506, A Novel NMDA Receptor Antagonist and Neuroprotectant: Review of Preclinical and Clinical Studies 1999 ·Annals of the New York Academy of Sciences ·Alan L. Mueller, Linda D. Artman, Manuel F. Balandrin, (unknown), (unknown), Eric G. DelMar, (unknown), (unknown), Thomas B. Marriott, Scott T. Moe, (unknown), J L Raszkiewicz, (unknown), Bradford C. Van Wagenen, David S. Wells	22
8	Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys. 1996 ·Drug Metabolism and Disposition ·David S. Wells, (unknown), (unknown), Patrick D. Brophy, Margaret Mullin, Edward J. Murray, George A. Ricca	1
9	Statistical Technique for Forecasting Concord Grape Production 1994 ·American Journal of Enology and Viticulture ·Raymond J. Folwell, (unknown), S. E. Spayd, (unknown), David S. Wells	7
10	Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. 1990 ·Drug Metabolism and Disposition ·JoAnn Scatina, David S. Wells, (unknown), (unknown), Samuel F. Sisenwine	3
11	Interactions between oxaprozin glucuronide and human serum albumin 1987 ·Xenobiotica ·David S. Wells, Frank W. Janssen, Hans W. Ruelius	42
12	The in‐vivo metabolism of propetamphos by insecticide‐resistant and susceptible strains of the housefly, Musca domestica 1986 ·Pesticide Science ·David S. Wells, N. Motoyama, W.C. Dauterman	5
13	Macrophage uptake of a lipoprotein-sequestered toxicant: A potential route of immunotoxicity 1986 ·Toxicology and Applied Pharmacology ·Naftali Kaminski, David S. Wells, W.C. Dauterman, John F. Roberts, F. E. Guthrie	10
14	In vitro metabolism of propetamphos by housefly, cockroach and mouse liver preparations 1986 ·Journal of Agricultural and Food Chemistry ·David S. Wells, (unknown), N. Motoyama, W.C. Dauterman	2
15	Perceptual grouping in schizophrenia: Replication of Place and Gilmore. 1984 ·Journal of Abnormal Psychology ·David S. Wells, (unknown)	57
16	Perceptual grouping in schizophrenia: Replication of Place and Gilmore. 1984 ·Journal of Abnormal Psychology ·David S. Wells, (unknown)	72
17	Studies on the mechanisms responsible for variable toxicity of azinphosmethyl to various larval instars of the tufted apple budmoth, Platynota idaeusalis 1983 ·Pesticide Biochemistry and Physiology ·David S. Wells, G. C. Rock, W.C. Dauterman	14
18	Desire for personal feedback: Who wants it and what does it mean for psychotherapy? 1982 ·Journal of Personality ·C. R. Snyder, Rick E. Ingram, Mitchell M. Handelsman, David S. Wells, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact